Avadel Appoints Chief Commercial Officer to Lead Anticipated Launch of Once-Nightly Sodium Oxybate
Responsibilities include leading the US commercial launch of the company’s lead program, once-nightly FT218, pending regulatory approval.
Read MoreResponsibilities include leading the US commercial launch of the company’s lead program, once-nightly FT218, pending regulatory approval.
Read MoreEnsoData: The journey of Sleep Review magazine’s current editor in chief, and how she hopes to continue providing sleep professionals with the news that matters.
Read MoreThe paper is unusual in that it includes four independently conducted experiments using different approaches to achieve a similar goal.
Read MoreThe findings add to what’s already known about the association between sleep, daily mood, and long-term risk of depression.
Read MoreThe researchers collected data on visually-impaired athletes who were active in Paralympic sports events in Japan.
Read More